aluates Reports

$ 0.0

Automative

Global mRNA Treatment Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-22U2563

Global mRNA Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global mRNA Treatment Market Research Report 2024

Code: QYRE-Auto-22U2563

Report

February 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CureVac

Moderna, Inc

BioNTech (Pfizer)

Sanofi (Translate Bio)

Ethris (AstraZeneca)

Kernal Biologics

RaNA Therapeutics

Silence Therapeutics

mRNA Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

mRNA Treatment Market

By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.

The global mRNA Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for mRNA Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Treatment.

Report Scope

The mRNA Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the mRNA Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of mRNA Treatment Market Report

Report Metric	Details
Report Name	mRNA Treatment Market
CAGR	5%
Segment by Type	Vaccine Drugs
Segment by Application	Protein Diseases Gene Dysfunction Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CureVac, Moderna, BioNTech (Pfizer), Sanofi (Translate Bio), Ethris (AstraZeneca), Kernal Biologics, RaNA Therapeutics, Silence Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the mRNA Treatment Market report?

Ans: The main players in the mRNA Treatment Market are CureVac, Moderna, BioNTech (Pfizer), Sanofi (Translate Bio), Ethris (AstraZeneca), Kernal Biologics, RaNA Therapeutics, Silence Therapeutics

What are the Application segmentation covered in the mRNA Treatment Market report?

Ans: The Applications covered in the mRNA Treatment Market report are Protein Diseases, Gene Dysfunction Diseases, Others

What are the Type segmentation covered in the mRNA Treatment Market report?

Ans: The Types covered in the mRNA Treatment Market report are Vaccine, Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Vaccine

1.2.3 Drugs

1.3 Market by Application

1.3.1 Global mRNA Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Protein Diseases

1.3.3 Gene Dysfunction Diseases

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Treatment Market Perspective (2019-2030)

2.2 mRNA Treatment Growth Trends by Region

2.2.1 Global mRNA Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 mRNA Treatment Historic Market Size by Region (2019-2024)

2.2.3 mRNA Treatment Forecasted Market Size by Region (2025-2030)

2.3 mRNA Treatment Market Dynamics

2.3.1 mRNA Treatment Industry Trends

2.3.2 mRNA Treatment Market Drivers

2.3.3 mRNA Treatment Market Challenges

2.3.4 mRNA Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Treatment Players by Revenue

3.1.1 Global Top mRNA Treatment Players by Revenue (2019-2024)

3.1.2 Global mRNA Treatment Revenue Market Share by Players (2019-2024)

3.2 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by mRNA Treatment Revenue

3.4 Global mRNA Treatment Market Concentration Ratio

3.4.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2023

3.5 mRNA Treatment Key Players Head office and Area Served

3.6 Key Players mRNA Treatment Product Solution and Service

3.7 Date of Enter into mRNA Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Treatment Breakdown Data by Type

4.1 Global mRNA Treatment Historic Market Size by Type (2019-2024)

4.2 Global mRNA Treatment Forecasted Market Size by Type (2025-2030)

5 mRNA Treatment Breakdown Data by Application

5.1 Global mRNA Treatment Historic Market Size by Application (2019-2024)

5.2 Global mRNA Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America mRNA Treatment Market Size (2019-2030)

6.2 North America mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America mRNA Treatment Market Size by Country (2019-2024)

6.4 North America mRNA Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe mRNA Treatment Market Size (2019-2030)

7.2 Europe mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe mRNA Treatment Market Size by Country (2019-2024)

7.4 Europe mRNA Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific mRNA Treatment Market Size (2019-2030)

8.2 Asia-Pacific mRNA Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific mRNA Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific mRNA Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America mRNA Treatment Market Size (2019-2030)

9.2 Latin America mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America mRNA Treatment Market Size by Country (2019-2024)

9.4 Latin America mRNA Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Treatment Market Size (2019-2030)

10.2 Middle East & Africa mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa mRNA Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa mRNA Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 CureVac

11.1.1 CureVac Company Detail

11.1.2 CureVac Business Overview

11.1.3 CureVac mRNA Treatment Introduction

11.1.4 CureVac Revenue in mRNA Treatment Business (2019-2024)

11.1.5 CureVac Recent Development

11.2 Moderna

11.2.1 Moderna Company Detail

11.2.2 Moderna Business Overview

11.2.3 Moderna mRNA Treatment Introduction

11.2.4 Moderna Revenue in mRNA Treatment Business (2019-2024)

11.2.5 Moderna Recent Development

11.3 BioNTech (Pfizer)

11.3.1 BioNTech (Pfizer) Company Detail

11.3.2 BioNTech (Pfizer) Business Overview

11.3.3 BioNTech (Pfizer) mRNA Treatment Introduction

11.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2019-2024)

11.3.5 BioNTech (Pfizer) Recent Development

11.4 Sanofi (Translate Bio)

11.4.1 Sanofi (Translate Bio) Company Detail

11.4.2 Sanofi (Translate Bio) Business Overview

11.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction

11.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2019-2024)

11.4.5 Sanofi (Translate Bio) Recent Development

11.5 Ethris (AstraZeneca)

11.5.1 Ethris (AstraZeneca) Company Detail

11.5.2 Ethris (AstraZeneca) Business Overview

11.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction

11.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2019-2024)

11.5.5 Ethris (AstraZeneca) Recent Development

11.6 Kernal Biologics

11.6.1 Kernal Biologics Company Detail

11.6.2 Kernal Biologics Business Overview

11.6.3 Kernal Biologics mRNA Treatment Introduction

11.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2019-2024)

11.6.5 Kernal Biologics Recent Development

11.7 RaNA Therapeutics

11.7.1 RaNA Therapeutics Company Detail

11.7.2 RaNA Therapeutics Business Overview

11.7.3 RaNA Therapeutics mRNA Treatment Introduction

11.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2019-2024)

11.7.5 RaNA Therapeutics Recent Development

11.8 Silence Therapeutics

11.8.1 Silence Therapeutics Company Detail

11.8.2 Silence Therapeutics Business Overview

11.8.3 Silence Therapeutics mRNA Treatment Introduction

11.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2019-2024)

11.8.5 Silence Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

CureVac

Moderna, Inc

BioNTech (Pfizer)

Sanofi (Translate Bio)

Ethris (AstraZeneca)

Kernal Biologics

RaNA Therapeutics

Silence Therapeutics

List of Tables

Table 1. Global mRNA Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Vaccine

Table 3. Key Players of Drugs

Table 4. Global mRNA Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global mRNA Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global mRNA Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global mRNA Treatment Market Share by Region (2019-2024)

Table 8. Global mRNA Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global mRNA Treatment Market Share by Region (2025-2030)

Table 10. mRNA Treatment Market Trends

Table 11. mRNA Treatment Market Drivers

Table 12. mRNA Treatment Market Challenges

Table 13. mRNA Treatment Market Restraints

Table 14. Global mRNA Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global mRNA Treatment Market Share by Players (2019-2024)

Table 16. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2023)

Table 17. Ranking of Global Top mRNA Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by mRNA Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players mRNA Treatment Product Solution and Service

Table 21. Date of Enter into mRNA Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global mRNA Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global mRNA Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global mRNA Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global mRNA Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global mRNA Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global mRNA Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global mRNA Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global mRNA Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America mRNA Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America mRNA Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe mRNA Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe mRNA Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific mRNA Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific mRNA Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific mRNA Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America mRNA Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America mRNA Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa mRNA Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa mRNA Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. CureVac Company Detail

Table 47. CureVac Business Overview

Table 48. CureVac mRNA Treatment Product

Table 49. CureVac Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 50. CureVac Recent Development

Table 51. Moderna Company Detail

Table 52. Moderna Business Overview

Table 53. Moderna mRNA Treatment Product

Table 54. Moderna Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 55. Moderna Recent Development

Table 56. BioNTech (Pfizer) Company Detail

Table 57. BioNTech (Pfizer) Business Overview

Table 58. BioNTech (Pfizer) mRNA Treatment Product

Table 59. BioNTech (Pfizer) Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 60. BioNTech (Pfizer) Recent Development

Table 61. Sanofi (Translate Bio) Company Detail

Table 62. Sanofi (Translate Bio) Business Overview

Table 63. Sanofi (Translate Bio) mRNA Treatment Product

Table 64. Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 65. Sanofi (Translate Bio) Recent Development

Table 66. Ethris (AstraZeneca) Company Detail

Table 67. Ethris (AstraZeneca) Business Overview

Table 68. Ethris (AstraZeneca) mRNA Treatment Product

Table 69. Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 70. Ethris (AstraZeneca) Recent Development

Table 71. Kernal Biologics Company Detail

Table 72. Kernal Biologics Business Overview

Table 73. Kernal Biologics mRNA Treatment Product

Table 74. Kernal Biologics Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 75. Kernal Biologics Recent Development

Table 76. RaNA Therapeutics Company Detail

Table 77. RaNA Therapeutics Business Overview

Table 78. RaNA Therapeutics mRNA Treatment Product

Table 79. RaNA Therapeutics Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 80. RaNA Therapeutics Recent Development

Table 81. Silence Therapeutics Company Detail

Table 82. Silence Therapeutics Business Overview

Table 83. Silence Therapeutics mRNA Treatment Product

Table 84. Silence Therapeutics Revenue in mRNA Treatment Business (2019-2024) & (US$ Million)

Table 85. Silence Therapeutics Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Global mRNA Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global mRNA Treatment Market Share by Type: 2023 VS 2030

Figure 3. Vaccine Features

Figure 4. Drugs Features

Figure 5. Global mRNA Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global mRNA Treatment Market Share by Application: 2023 VS 2030

Figure 7. Protein Diseases Case Studies

Figure 8. Gene Dysfunction Diseases Case Studies

Figure 9. Others Case Studies

Figure 10. mRNA Treatment Report Years Considered

Figure 11. Global mRNA Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global mRNA Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global mRNA Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global mRNA Treatment Market Share by Players in 2023

Figure 15. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by mRNA Treatment Revenue in 2023

Figure 17. North America mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America mRNA Treatment Market Share by Country (2019-2030)

Figure 19. United States mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe mRNA Treatment Market Share by Country (2019-2030)

Figure 23. Germany mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific mRNA Treatment Market Share by Region (2019-2030)

Figure 31. China mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America mRNA Treatment Market Share by Country (2019-2030)

Figure 39. Mexico mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa mRNA Treatment Market Share by Country (2019-2030)

Figure 43. Turkey mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia mRNA Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. CureVac Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 46. Moderna Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 47. BioNTech (Pfizer) Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 48. Sanofi (Translate Bio) Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 49. Ethris (AstraZeneca) Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 50. Kernal Biologics Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 51. RaNA Therapeutics Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 52. Silence Therapeutics Revenue Growth Rate in mRNA Treatment Business (2019-2024)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global and US mRNA Vaccine

mRNA Cancer Vaccines and Therapeutics

mRNA Sequencing

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions